256 related articles for article (PubMed ID: 24392665)
21. Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
Harada N; Kimura H; Ono M; Saji H
J Med Chem; 2013 Oct; 56(20):7890-901. PubMed ID: 24063417
[TBL] [Abstract][Full Text] [Related]
22. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Binding of a Novel PSMA-specific Conjugate.
Holmberg AR; Marquez M; Lennartsson L; Meurling L; Nilsson S
Anticancer Res; 2018 Mar; 38(3):1531-1537. PubMed ID: 29491082
[TBL] [Abstract][Full Text] [Related]
24. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
[TBL] [Abstract][Full Text] [Related]
25. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
26. (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.
Kiess AP; Minn I; Vaidyanathan G; Hobbs RF; Josefsson A; Shen C; Brummet M; Chen Y; Choi J; Koumarianou E; Baidoo K; Brechbiel MW; Mease RC; Sgouros G; Zalutsky MR; Pomper MG
J Nucl Med; 2016 Oct; 57(10):1569-1575. PubMed ID: 27230930
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
[TBL] [Abstract][Full Text] [Related]
28. Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.
Kasten BB; Liu T; Nedrow-Byers JR; Benny PD; Berkman CE
Bioorg Med Chem Lett; 2013 Jan; 23(2):565-8. PubMed ID: 23232055
[TBL] [Abstract][Full Text] [Related]
29. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
Eder M; Schäfer M; Bauder-Wüst U; Hull WE; Wängler C; Mier W; Haberkorn U; Eisenhut M
Bioconjug Chem; 2012 Apr; 23(4):688-97. PubMed ID: 22369515
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
Ngen EJ; Chen Y; Azad BB; Boinapally S; Jacob D; Lisok A; Shen C; Hossain MS; Jin J; Bhujwalla ZM; Pomper MG; Banerjee SR
Nanotheranostics; 2021; 5(2):182-196. PubMed ID: 33564617
[TBL] [Abstract][Full Text] [Related]
31. Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
Pearce AK; Fuchs AV; Fletcher NL; Thurecht KJ
Pharm Res; 2016 Oct; 33(10):2388-99. PubMed ID: 27225496
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and
Cordonnier A; Boyer D; Besse S; Valleix R; Mahiou R; Quintana M; Briat A; Benbakkar M; Penault-Llorca F; Maisonial-Besset A; Maunit B; Tarrit S; Vivier M; Witkowski T; Mazuel L; Degoul F; Miot-Noirault E; Chezal JM
J Mater Chem B; 2021 Sep; 9(36):7423-7434. PubMed ID: 34373887
[TBL] [Abstract][Full Text] [Related]
34. PSMA-targeted dendrimer as an efficient anticancer drug delivery vehicle for prostate cancer.
Dhull A; Wei J; Pulukuri AJ; Rani A; Sharma R; Mesbahi N; Yoon H; Savoy EA; Xaivong Vi S; Goody KJ; Berkman CE; Wu BJ; Sharma A
Nanoscale; 2024 Mar; 16(11):5634-5652. PubMed ID: 38440933
[TBL] [Abstract][Full Text] [Related]
35. Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer.
Cho S; Zammarchi F; Williams DG; Havenith CEG; Monks NR; Tyrer P; D'Hooge F; Fleming R; Vashisht K; Dimasi N; Bertelli F; Corbett S; Adams L; Reinert HW; Dissanayake S; Britten CE; King W; Dacosta K; Tammali R; Schifferli K; Strout P; Korade M; Masson Hinrichs MJ; Chivers S; Corey E; Liu H; Kim S; Bander NH; Howard PW; Hartley JA; Coats S; Tice DA; Herbst R; van Berkel PH
Mol Cancer Ther; 2018 Oct; 17(10):2176-2186. PubMed ID: 30065100
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a PSMA-targeted BNF nanoparticle construct.
Behnam Azad B; Banerjee SR; Pullambhatla M; Lacerda S; Foss CA; Wang Y; Ivkov R; Pomper MG
Nanoscale; 2015 Mar; 7(10):4432-42. PubMed ID: 25675333
[TBL] [Abstract][Full Text] [Related]
37. Discovery of PSMA-specific peptide ligands for targeted drug delivery.
Jin W; Qin B; Chen Z; Liu H; Barve A; Cheng K
Int J Pharm; 2016 Nov; 513(1-2):138-147. PubMed ID: 27582001
[TBL] [Abstract][Full Text] [Related]
38. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes.
Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387
[TBL] [Abstract][Full Text] [Related]
39. Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer.
Lesniak WG; Wu Y; Kang J; Boinapally S; Ray Banerjee S; Lisok A; Jablonska A; Boctor EM; Pomper MG
Nanoscale; 2021 May; 13(20):9217-9228. PubMed ID: 33978042
[TBL] [Abstract][Full Text] [Related]
40. Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels.
Sillerud LO
Int J Nanomedicine; 2016; 11():357-71. PubMed ID: 26855574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
